Campbell’s Company Reports Q3 Fiscal 2026 Results: Key Details for Investors
Overview
The Campbell’s Company (NASDAQ: CPB) has released its financial results for the third quarter of fiscal 2026, ended May 3, 2026. The report presents a mixed picture, with some positive developments but also notable challenges, especially regarding sales declines, margin pressures, and cost inflation. The company reaffirmed its full-year guidance despite ongoing headwinds.
Key Financial Highlights
- Net Sales: Decreased 4% to \$2.4 billion on both reported and organic bases.
- EBIT (Earnings Before Interest and Taxes): Increased to \$239 million (up 48% from prior year due to last year’s impairment charge). Adjusted EBIT decreased 24% to \$274 million due to lower gross profit.
- EPS (Earnings Per Share): Reported EPS rose to \$0.41 (up from \$0.22). Adjusted EPS dropped 32% to \$0.50 (from \$0.73).
- Cash Flow: Year-to-date cash flow from operations was \$839 million, slightly down from \$872 million last year.
- Cost Savings: \$20 million savings achieved this quarter; total cost savings hit \$200 million toward the \$375 million fiscal 2028 target.
- Dividends: \$380 million returned to shareholders year-to-date, primarily via dividends.
Segment Performance
-
Meals & Beverages:
- Net sales declined 4%, driven by unfavorable volume/mix (-5%), partially offset by favorable net price realization (+1%).
- U.S. soup sales dropped 8%, mainly due to lower sales in condensed and ready-to-serve soups.
- Operating earnings decreased 16% due to gross impact of tariffs, cost inflation, supply chain costs, and unfavorable volume/mix. Productivity improvements and cost savings initiatives provided partial offsets.
-
Snacks:
- Net sales (reported and organic) fell 4%, primarily due to unfavorable volume/mix (-6%) despite net price realization (+2%).
- Declines were mainly in salty snacks, crackers, and fresh bakery. Third-party partner brands and contract manufacturing sales were also a headwind.
- Operating earnings decreased 32% due to elevated cost inflation, supply chain costs, unfavorable volume/mix, and tariffs. Productivity improvements and cost savings initiatives helped offset some losses.
Margin and Expense Details
- Gross Profit: Down 11% to \$650 million. Gross margin contracted 190 basis points to 27.5%; adjusted gross margin fell 240 basis points to 27.7%.
- Marketing & Selling Expenses: Down 1% to \$214 million; adjusted expenses up 2% to \$211 million due to increased marketing spend.
- Administrative Expenses: Down 4% to \$155 million; adjusted expenses decreased 1% to \$149 million, mainly due to cost savings and lower incentive compensation.
- Other Expenses: \$8 million, down from \$160 million last year (which included a \$150 million impairment charge).
Guidance and Outlook
- Fiscal 2026 Guidance Reaffirmed: Organic net sales expected to decline 2% to 1%. Adjusted EBIT to decline 20% to 17%. Adjusted EPS forecasted to drop 26% to 23% (\$2.15–\$2.25).
- Guidance excludes: Impact of the 53rd week in fiscal 2025, divestitures of noosa (completed Feb 2025) and Pop Secret (completed Aug 2024), and currency fluctuations.
Items Impacting Comparability
Adjustments to reported results include cost savings and optimization initiatives, commodity mark-to-market gains/losses, acquisition-related costs, litigation expenses, pension gains/losses, impairment charges, accelerated amortization, and divestiture impacts. Notably:
- Q3 2026: \$69 million in costs related to savings and optimization initiatives (\$52 million after tax, \$0.17/share).
- Pension actuarial and curtailment gains of \$30 million (\$23 million after tax, \$0.08/share).
- Acquisition costs related to La Regina: \$2 million (\$2 million after tax, \$0.01/share).
- Litigation expenses: \$11 million (\$8 million after tax, \$0.03/share) in nine months of fiscal 2026.
- No impairment charges in Q3 2026; prior year included \$150 million impairment (\$112 million after tax, \$0.37/share).
- Sale of noosa and Pop Secret businesses in fiscal 2025 impacted comparability.
Balance Sheet and Cash Flow
- Total Assets: \$15.1 billion (up from \$14.8 billion last year).
- Cash and Equivalents: \$402 million (up from \$143 million).
- Long-Term Debt: \$6.1 billion.
- Total Equity: \$4.0 billion.
Operating cash flow for nine months was \$839 million. Capital expenditures were \$297 million, nearly flat year-over-year. Net cash used in investing activities was \$298 million, mainly for plant assets and routes; net cash used in financing activities was \$272 million, primarily for debt repayments and dividends.
Strategic Actions and Risks
- Progress in cost savings: \$200 million achieved toward a \$375 million target for fiscal 2028.
- Ongoing headwinds: Cost inflation, tariffs, supply chain costs, and softer volumes are impacting margins and profitability.
- Divestitures: Completed sales of noosa and Pop Secret businesses; impacts reflected in results and guidance.
- Acquisition: Completed purchase of La Regina, which may impact future results and synergies.
- Litigation and regulatory risks: Ongoing cases related to Plum and other matters; cybersecurity recoveries noted.
- Impairment risk: No impairment charges in Q3 2026, but past charges (notably on Snyder’s of Hanover, Allied brands, Late July) were significant.
- Guidance caveats: Non-GAAP reconciliations are not provided for full-year guidance due to unpredictability of certain items (e.g., pension actuarial gains/losses).
Shareholder Returns
Campbell’s has maintained its commitment to shareholder returns, paying out \$380 million year-to-date, primarily via dividends. However, the decline in adjusted EPS and EBIT, along with sales contraction, may be of concern to investors.
Conference Call Details
A conference call to discuss the results is scheduled for June 8, 2026, at 9:00 a.m. Eastern Time. Presentation materials and remarks are available on the Campbell’s investor relations website.
Potential Price-Sensitive Factors
- Sales Decline and Margin Pressure: Continued contraction in volumes and gross margins, especially in core segments (Meals & Beverages, Snacks).
- Cost Inflation and Tariffs: Ongoing cost headwinds impacting profitability.
- Guidance Reaffirmation: Despite headwinds, Campbell’s maintained its guidance—this may reassure or disappoint investors depending on expectations.
- Impairment Risks: No new impairments, but prior year impacts were significant; investors may watch for further write-downs.
- Strategic Divestitures and Acquisitions: Completed sales of noosa and Pop Secret, acquisition of La Regina—future synergies and impacts will be closely watched.
- EPS Drop: Adjusted EPS down 32% year-on-year; this is a key metric for shareholders.
- Cost Savings Progress: Achievement of savings targets is critical to offset inflationary pressures.
- Litigation and Regulatory Risks: Ongoing litigation and regulatory actions could impact future results.
Conclusion
Campbell’s Q3 2026 financial report highlights challenging market conditions and ongoing cost pressures, but also shows commitment to cost savings, shareholder returns, and strategic portfolio actions. Investors should closely monitor sales trends, margin recovery efforts, progress on cost savings, and impacts of acquisitions and divestitures. The reaffirmation of guidance, despite margin pressure and sales declines, is notable and may be a focal point for share price movement. Any further deterioration in volumes, margins, or unexpected impairment/litigation charges could be price-sensitive.
Disclaimer: The information provided herein is based on Campbell’s Company official financial filings and press releases for Q3 fiscal 2026. This article is intended for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The author assumes no responsibility for any losses arising from reliance on the information presented.
